Targeted molecular therapies represent a groundbreaking approach in the fight against cancer, aiming to specifically disrupt the mechanisms that drive oncogenic processes.By focusing on genetic mutations and their impact on protein interactions, researchers have unlocked new pathways for treating various malignancies.